Fibroblast-conditioned medium

Fibroblast-conditioned medium has been studied in 2 papers since 2018: 1 observational study in people, 1 in cells; 1 in the past year. The newest paper, Nov 12, 2026: “Multi-omics and Machine Learning Identify Senescence Targets Linked to CXCL12–CXCR4 T-Cell Responses in Periodontitis”.

Intervention

2 papers study it1 findingUpdated

1 new paper in 30 daysSee all 2 papers on fibroblast-conditioned medium

At a glance

The findings reach cells, none yet in people. 1 lab in 1 country.

Cells: a single group. Worms or flies, mice and humans: nothing yet.
  • 1 lab in 1 country
  • Funders: Ministerstvo Školství, Mládeže a Tělovýchovy and 1 more
  • Humans1
  • Cells1

What did studies of fibroblast-conditioned medium find?

1

Studies of fibroblast-conditioned medium measured one outcome, DNMT1 degradation.

DNMT1 degradation

downin cells1

1 study
  1. Fibroblast-conditioned medium inhibits DNMT1 degradation in cells (decitabine treatment).

    “abrogated DAC effect on degradation of DNA methyltransferase 1.”

    Cellsdecitabine treatmentconditioned medium from senescent fibroblastscolorectal cancer cell

    Differential Regulation of Methylation-Regulating Enzymes by Senescent Stromal Cells Drives Colorectal Cancer Cell Response to DNA-Demethylating Epi-Drugs

    Stem cells international

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 11 paper in 12 months